Helping patients find the head and neck cancer
resources they deserve
How do we help head and neck cancer patients?
Massive Bio offers an independent cancer treatment analysis as well as free clinical trial matching for head and neck cancer patients. Our patient advocates work closely with patients to gather information on their current medical status, and then will provide a list of options from available cancer clinical trials close to your home.
We can also provide a second opinion through our Virtual Tumor Board from cancer specialists. The Virtual Tumor Board (VTB) is comprised of highly specialized oncologists from nationally-recognized Cancer Centers of Excellence. In just 7-10 days after receiving your medical records, we can get you a treatment plan without having to travel far distances and use your valuable time.
There are approximately 539 Head & Neck Cancer clinical trials that are currently patients in the United States right now. With such an extensive list, many of them could be beneficial for you. Our team of patient advocates, who are oncology nurses, and our artificial intelligence based clinical trial matching system will find the best option for you.
A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC.
With just a few clicks, you can see your clinical trial matches now. Click here to use our advanced clinical trial match tool.
Head and Neck Cancer Facts
Head & Neck Cancer can occur in any of the:
Paranasal sinuses and nasal cavity
These cancer types can cause complications that are not normally associated with most other cancer types. For example, a person’s chewing and talking abilities can be damaged either temporarily or permanently. Taste is often affected while going through treatment which can lead to loss of appetite and hinder the patient’s nutrition. Head and neck cancer is usually not found until issues in the body cause a patient to go to the doctor.
The two biggest risk factors for head & neck cancer is smoking and alcohol. It is estimated that 75% of these cancer cases come from those with a history of alcohol or tobacco use. Using both alcohol and tobacco puts you at an even greater risk of developing cancer. Cancer that occurs in the salivary glands has been observed to not correlate with smoking and tobacco use. Like other cancer types, Epstein-Barr virus infection can lead to cancer in the salivary glands.
Common treatment methods for Head & Neck Cancer include but are not limited to:
Radiation (Typically done after surgery)
Chemotherapy (Typically used with late stage cancers)
Head & Neck Cancer is different from other types of cancer when it comes to screening. Doctors often look for lesions in the mouth that could become cancerous. By the time they are discovered, oral cancer has already spread to other parts of the body, usually in the lymph nodes. There is no real way to screen for this cancer type other than routine examinations by doctors and dentists. However, if lesions are found, there are a few ways to get a better idea if they are cancerous:
Toluidine blue stain
Head & Neck cancer is twice as popular in men as women. Accounts for 4% of all cancer cases. The five-year survival rate is currently 65.3% which is slightly lower than the average five-year survival rate for all cancer types (70%). Since 1975 the number of Head & Neck Cancer cases has decreased slightly from 11.7 people per 100,000 to 10.9 people. As for the death rate, it has mirrored the slight decline of cases since 1975. The number of deaths went from 3.3 people per 100,000 to 2.6 people. There are roughly 370,000 people with Head & Neck Cancer in the United States today.
The five main types of Head & Neck Cancer:
Laryngeal and hypopharyngeal cancer
Nasal cavity and paranasal sinus cancer
Oral and oropharyngeal cancer
Salivary gland cancer
Our team of patient advocates can help guide you to treatment options you might not have been previously aware of. Although you might be new to cancer, we certainly are not. Navigating cancer patients through the tricky path of finding the best treatment is our goal. No two cancer patients are alike, which is why we find treatment for all of our patients based on their specific genomics, location, stage of cancer, and nearly 100 more data points.